---
company: HAWKINS INC
ticker: HWKN
form: 8-K
filed: 2026-10-26
accession: 0000046250-26-000043
source: https://www.sec.gov/Archives/edgar/data/46250/000004625026000043/
---

# Hawkins (HWKN) earnings release, October 26, 2026

Hawkins Inc (HWKN) · Form 8-K, Item 2.02 · Filed 2026-10-26 · [SEC filing](https://www.sec.gov/Archives/edgar/data/46250/000004625026000043/)

Hawkins, Inc. Reports

Second Quarter Fiscal 2027 Results

Roseville, Minn., October 26, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for its second quarter of fiscal 2027, the three months ended September 27, 2026.

Second Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the second quarter of fiscal 2026 unless otherwise noted.)

• Record second quarter revenue of $313.8 million, with growth of 12%, driven by increased sales across all segments, including Water Treatment segment growth of 16%, Food & Health Sciences segment growth of 5%, and Industrial Solutions segment growth of 10%.

• Record second quarter gross profit of $76.6 million, an increase of 13%.

• Record second quarter diluted earnings per share ("EPS") of $1.34 increased $0.25, or 23%.

• Record second quarter net income of $27.8 million increased 23%, with record trailing twelve-month net income of $85.8 million. Record Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $59.1 million, a 16% increase. Record trailing twelve-month adjusted EBITDA of $188.0 million.

• Generated operating cash flow of $75.5 million, an increase of 6% for the six months ended September 27, 2026. Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased 14% to $53.1 million compared to the same period in the prior year, which we allocated to repurchasing $18.6 million of stock, paying down $15.0 million of debt and paying $8.1 million in dividends.

• Closed our second acquisition of fiscal 2027 with the purchase of Dave Symonds & Associates, Inc., a blended phosphates for corrosion control and sequestration focused water distributor based in Florida.

• Subsequent to quarter end, we expanded into the Dallas–Fort Worth region, pairing our greenfield Water Treatment facility with the acquisition of Eagle Labs, Inc., a water treatment distributor with in-house manufacturing capabilities and expertise in coagulants and polymers.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our record second-quarter results in revenue, gross profit, EPS, and adjusted EBITDA reflect the agility of our employees and the resilience of our business model,” said Patrick Hawkins, President and Chief Executive Officer. “Revenue grew 12% in the quarter, including organic growth of 11%, with all three segments growing and Water Treatment revenue up 16%, primarily driven by increased volumes. Gross profit grew 13%, again led by Water Treatment at 20%, driven by volume growth and higher per-unit dollar margins. That gross profit growth flowed through to the bottom line, with diluted EPS up 23% and record adjusted EBITDA of $59 million, up 16%.”

Mr. Hawkins continued, “We continue to generate strong cash flow. During the quarter, we repurchased $12 million of our stock, paid down $15 million of debt, and closed on the acquisition of Dave Symonds & Associates, a tuck-in that expands our Water Treatment customer reach in Florida. Our leverage ratio at the end of the second quarter was 1.22x adjusted EBITDA, down from 1.37x at the end of fiscal 2026 and 1.54x in the same quarter last year. Subsequent to quarter end, we closed on the acquisition of Eagle Labs, which adds two locations in the Dallas–Fort Worth region, continuing our expansion in Texas. We will continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and serving the needs of our customers to the highest level possible.”

Mr. Hawkins concluded, “Looking forward we expect the second half trends to be consistent with what we saw in the first half, recognizing that SG&A in the second half of fiscal 2026 benefited from a non-recurring $6.2 million reduction in SG&A which will not recur in the second half of fiscal 2027.”

Second Quarter Financial Highlights:

NET INCOME

For the second quarter of fiscal 2027, we reported net income of $27.8 million, or $1.34 per diluted share, compared to net income for the second quarter of fiscal 2026 of $22.6 million, or $1.08 per diluted share.

REVENUE

Sales were $313.8 million for the second quarter of fiscal 2027, an increase of $33.4 million, or 12%, from sales of $280.4 million in the same period a year ago. All of our segments grew by 5% or more from the same period a year ago. Sales increased as a result of 11% organic sales growth and approximately $3.7 million of sales from acquired businesses.

Water Treatment segment sales increased $24.1 million, or 16%, to $175.0 million for the current quarter, from $150.9 million in the same period a year ago. Organic sales grew 14%, driven primarily by increased volumes, along with improved pricing on certain of our products. Growth was broad-based across our product lines and end markets, with the municipal end market particularly strong. Acquired businesses contributed approximately $3.7 million in additional sales.

Food & Health Sciences segment sales increased $3.8 million, or 5%, to $76.7 million for the current quarter, from $72.9 million in the same period a year ago. Sales dollars increased as a result of increased volumes of our nutrition, food ingredients, and pharmaceutical products, partially offset by decreased sales of our agricultural products.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $62.2 million for the current quarter, from $56.6 million in the same period a year ago. Sales increased as a result of improved pricing and favorable product mix, which more than offset lower volumes.

GROSS PROFIT... (truncated)ased, and gross profit decreased, by $0.3 million. The $1.6 million year-over-year impact of the unfavorable LIFO reserve was partially offset by $1.3 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The refunded tariffs related to products for which customer pricing had not been increased in response to tariffs. Gross profit was also pressured by higher fuel costs that were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $8.4 million, or 20%, to $51.7 million, or 30% of sales, for the current quarter, from $43.3 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.5 million. In the same period a year ago, the LIFO reserve decreased, and gross profit increased minimally. The $0.5 million year-over-year impact of the unfavorable LIFO reserve was more than offset by $1.2 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The increase in gross profit was primarily driven by higher sales.

Gross profit for the Food & Health Sciences segment decreased $0.6 million, or 4%, to $14.9 million, or 19% of sales, for the current quarter, from $15.5 million, or 21% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.2 million. Gross profit decreased as lower margins in our food and pharmaceutical products and the $0.5 million year-over-year impact of the unfavorable LIFO reserve more than offset the benefit of higher segment sales and improved margins in our nutrition and agriculture products.

Gross profit for the Industrial Solutions segment increased $1.1 million, or 12%, to $10.0 million, or 16% of sales, for the current quarter, from $8.9 million, or 16% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.1 million. The benefit of higher sales and favorable product mix was partially offset by the $0.6 million year-over-year impact of the unfavorable LIFO reserve.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative (“SG&A”) expenses increased $1.0 million, or 3%, to $34.7 million, or 11% of sales, for the three months ended September 27, 2026, from $33.7 million, or 12% of sales, in the same period a year ago. This included $0.4 million due to added costs from the acquired businesses in our Water Treatment segment. SG&A expenses also increased due to increases in other variable costs, including variable pay and other personnel costs. These increases were partially offset by a $0.5 million decrease in non-qualified deferred compensation plan expense, as appreciation in the market value of plan investments was lower than in the same period a year ago. Deferred compensation plan expense is offset by a corresponding gain on plan investments recorded in other income (expense).

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended September 27, 2026 was $59.1 million, an increase of $8.2 million, or 16%, from $50.9 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended September 28, 2025 was $50.4 million, which included non-cash earnout related expense that is excluded under the current definition.

INCOME TAXES

Our effective income tax rate was 30% for the current quarter and 27% for the same period a year ago. The effective income tax rate for each period exceeded the U.S. federal statutory rate of 21%, primarily due to state income taxes on non-deductible expenses, including executive compensation and other permanent items. The increase in the effective income tax rate compared with prior-periods was primarily due to higher state income taxes and an increase in non-deductible items. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, state taxes and discrete items, including tax effects of stock-based compensation. Our effective tax rate for the full year is expected to be approximately 25% to 27%.

## Financial statements

### Income Statement (Adjusted EBITDA (in thousands))

| | Three months ended – September 27, 2026 | Three months ended – September 28, 2025 | Six months ended – September 27, 2026 | Six months ended – September 28, 2025 | Trailing Twelve months ended – September 27, 2026 |
|---|---:|---:|---:|---:|---:|
| Net Income (GAAP) | 27,781 | 22,598 | 56,035 | 51,773 | 85,810 |
| Interest expense, net | 2,643 | 3,832 | 5,416 | 7,101 | 11,822 |
| Income tax expense | 11,746 | 8,231 | 20,816 | 18,062 | 30,546 |
| Amortization of intangibles | 5,503 | 5,527 | 11,019 | 10,348 | 21,963 |
| Depreciation expense | 8,792 | 7,735 | 17,221 | 15,205 | 33,266 |
| Non-cash compensation expense | 1,933 | 2,375 | 4,168 | 4,587 | 8,154 |
| Non-recurring acquisition expenses (1) | 140 | 70 | 203 | 940 | 501 |
| Non-cash earnout related expense (income) | 552 | 535 | 1,087 | -1,048 | -4,042 |
| Adjusted EBITDA | 59,090 | 50,903 | 115,965 | 106,968 | 188,020 |

### Income Statement (Three months ended — (In thousands, except share and per-share data))

| | Three months ended – September 27, 2026 | Three months ended – September 28, 2025 | Six months ended – September 27, 2026 | Six months ended – September 28, 2025 |
|---|---:|---:|---:|---:|
| Sales | 313,817 | 280,434 | 629,492 | 573,706 |
| Cost of sales | -237,211 | -212,791 | -478,879 | -433,701 |
| Gross profit | 76,606 | 67,643 | 150,613 | 140,005 |
| Selling, general and administrative expenses | -34,700 | -33,703 | -70,035 | -64,732 |
| Operating income | 41,906 | 33,940 | 80,578 | 75,273 |
| Interest expense, net | -2,643 | -3,832 | -5,416 | -7,101 |
| Other income | 264 | 721 | 1,689 | 1,663 |
| Income before income taxes | 39,527 | 30,829 | 76,851 | 69,835 |
| Income tax expense | -11,746 | -8,231 | -20,816 | -18,062 |
| Net income | 27,781 | 22,598 | 56,035 | 51,773 |
| Weighted average number of shares outstanding - basic | 20,710,228 | 20,737,743 | 20,743,855 | 20,727,614 |
| Weighted average number of shares outstanding - diluted | 20,783,044 | 20,845,744 | 20,827,219 | 20,837,595 |
| Basic earnings per share | 1.34 | 1.09 | 2.7 | 2.5 |
| Diluted earnings per share | 1.34 | 1.08 | 2.69 | 2.48 |
| Cash dividends declared per common share | 0.2 | 0.19 | 0.39 | 0.37 |

### Income Statement (Water Treatment — (In thousands) (in thousands))

| | Three months ended September 27, 2026: – Water Treatment | Three months ended September 27, 2026: – Food & Health Sciences | Three months ended September 27, 2026: – Industrial Solutions | Three months ended September 27, 2026: – Total |
|---|---:|---:|---:|---:|
| Sales | 174,961 | 76,679 | 62,177 | 313,817 |
| Cost of sales - materials | -104,388 | -57,350 | -49,294 | -211,032 |
| Cost of sales - operational overhead | -18,824 | -4,432 | -2,923 | -26,179 |
| Gross profit | 51,749 | 14,897 | 9,960 | 76,606 |
| Selling, general, and administrative expenses | -23,477 | -7,941 | -3,282 | -34,700 |
| Operating income | 28,272 | 6,956 | 6,678 | 41,906 |
| Three months ended September 28, 2025: | Sales | 150,908 | 72,914 | 56,612 | 280,434 |
| Three months ended September 28, 2025: | Cost of sales - materials | -88,814 | -53,153 | -45,131 | -187,098 |
| Three months ended September 28, 2025: | Cost of sales - operational overhead | -18,833 | -4,280 | -2,580 | -25,693 |
| Three months ended September 28, 2025: | Gross profit | 43,261 | 15,481 | 8,901 | 67,643 |
| Three months ended September 28, 2025: | Selling, general, and administrative expenses | -22,071 | -8,084 | -3,548 | -33,703 |
| Three months ended September 28, 2025: | Operating income | 21,190 | 7,397 | 5,353 | 33,940 |
| Six months ended September 27, 2026: | Sales | 333,254 | 173,929 | 122,309 | 629,492 |
| Six months ended September 27, 2026: | Cost of sales - materials | -198,869 | -130,695 | -97,152 | -426,716 |
| Six months ended September 27, 2026: | Cost of sales - operational overhead | -37,140 | -9,062 | -5,961 | -52,163 |
| Six months ended September 27, 2026: | Gross profit | 97,245 | 34,172 | 19,196 | 150,613 |
| Six months ended September 27, 2026: | Selling, general, and administrative expenses | -47,147 | -15,969 | -6,919 | -70,035 |
| Six months ended September 27, 2026: | Operating income | 50,098 | 18,203 | 12,277 | 80,578 |
| Six months ended September 28, 2025: | Sales | 300,474 | 162,091 | 111,141 | 573,706 |
| Six months ended September 28, 2025: | Cost of sales - materials | -177,973 | -118,967 | -87,979 | -384,919 |
| Six months ended September 28, 2025: | Cost of sales - operational overhead | -35,493 | -8,295 | -4,994 | -48,782 |
| Six months ended September 28, 2025: | Gross profit | 87,008 | 34,829 | 18,168 | 140,005 |
| Six months ended September 28, 2025: | Selling, general, and administrative expenses | -41,156 | -16,465 | -7,111 | -64,732 |
| Six months ended September 28, 2025: | Operating income | 45,852 | 18,364 | 11,057 | 75,273 |

### Balance Sheet ((In thousands, except share data))

| | September 27, 2026 | March 29, 2026 |
|---|---:|---:|
| CURRENT ASSETS: | Cash and cash equivalents | 7,100 | 3,914 |
| CURRENT ASSETS: | Trade accounts receivables, net | 149,281 | 139,796 |
| CURRENT ASSETS: | Inventories | 92,947 | 78,199 |
| CURRENT ASSETS: | Prepaid expenses and other current assets | 7,793 | 9,556 |
| CURRENT ASSETS: | Total current assets | 257,121 | 231,465 |
| CURRENT ASSETS: | Property, plant, and equipment | 509,360 | 489,662 |
| CURRENT ASSETS: | Less accumulated depreciation | 237,614 | 223,406 |
| CURRENT ASSETS: | Net property, plant, and equipment | 271,746 | 266,256 |
| OTHER ASSETS: | Right-of-use assets, net | 17,170 | 16,840 |
| OTHER ASSETS: | Goodwill | 224,439 | 223,042 |
| OTHER ASSETS: | Intangible assets, net | 224,455 | 232,887 |
| OTHER ASSETS: | Deferred compensation plan asset | 15,649 | 12,812 |
| OTHER ASSETS: | Other | 1,472 | 2,988 |
| OTHER ASSETS: | Total other assets | 483,185 | 488,569 |
| OTHER ASSETS: | Total assets | 1,012,052 | 986,290 |
| CURRENT LIABILITIES: | Accounts payable — trade | 69,609 | 59,835 |
| CURRENT LIABILITIES: | Accrued payroll and employee benefits | 15,746 | 20,092 |
| CURRENT LIABILITIES: | Income tax payable | 5,025 | 98 |
| CURRENT LIABILITIES: | Environmental remediation | 7,700 | 7,700 |
| CURRENT LIABILITIES: | Other current liabilities | 14,676 | 17,119 |

### Cash Flow (Free Cash Flow Reconciliation (in thousands))

| | Six months ended – September 27, 2026 | Six months ended – September 28, 2025 |
|---|---:|---:|
| Net cash provided by operating activities | 75,488 | 71,031 |
| Less: Purchases of property, plant & equipment | -22,355 | -24,342 |
| Free cash flow | 53,133 | 46,689 |

### Cash Flow (Six months ended — (In thousands) (in thousands))

| | Six months ended – September 27, 2026 | Six months ended – September 28, 2025 |
|---|---:|---:|
| CASH FLOWS FROM OPERATING ACTIVITIES: | Net income | 56,035 | 51,773 |
| Reconciliation to cash flows: | Depreciation and amortization | 28,240 | 25,553 |
| Reconciliation to cash flows: | Change in fair value of earnout liabilities | 1,087 | -1,048 |
| Reconciliation to cash flows: | Operating leases | 2,121 | 1,881 |
| Reconciliation to cash flows: | Gain on deferred compensation assets | -1,689 | -1,664 |
| Reconciliation to cash flows: | Deferred income taxes | 1,131 |  |
| Reconciliation to cash flows: | Stock compensation expense | 4,168 | 4,587 |
| Reconciliation to cash flows: | Other, net | -60 | 8 |
| Changes in operating accounts providing (using) cash: | Trade receivables | -9,949 | 5,140 |
| Changes in operating accounts providing (using) cash: | Inventories | -14,550 | -5,196 |
| Changes in operating accounts providing (using) cash: | Accounts payable | 9,676 | -11,013 |
| Changes in operating accounts providing (using) cash: | Accrued liabilities | -6,320 | -4,209 |
| Changes in operating accounts providing (using) cash: | Lease liabilities | -2,376 | -1,897 |
| Changes in operating accounts providing (using) cash: | Income taxes | 5,173 | 4,082 |
| Changes in operating accounts providing (using) cash: | Other, net | 2,801 | 3,034 |
| Changes in operating accounts providing (using) cash: | Net cash provided by operating activities | 75,488 | 71,031 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Purchases of property, plant, and equipment | -22,355 | -24,342 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Acquisitions | -5,200 | -162,508 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Proceeds from asset disposals | 517 | 1,037 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Net cash used in investing activities | -27,038 | -185,813 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Cash dividends declared and paid | -8,136 | -7,723 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | New shares issued | 1,681 | 1,609 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Payroll taxes paid in exchange for shares withheld | -5,143 | -3,028 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Shares repurchased | -18,646 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Payments on senior secured revolving loan | -20,000 | -40,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Payments for debt issuance costs |  | -764 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Borrowings on senior secured revolving loan | 5,000 | 170,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Other | -20 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Net cash (used in) provided by financing activities | -45,264 | 120,094 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | NET INCREASE IN CASH AND CASH EQUIVALENTS | 3,186 | 5,312 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 3,914 | 5,103 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | CASH AND CASH EQUIVALENTS, END OF PERIOD | 7,100 | 10,415 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | Cash paid for income taxes | 14,512 | 13,980 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | Cash paid for interest | 5,480 | 7,182 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | Noncash investing activities - capital expenditures in accounts payable | 2,273 | 1,568 |
